Summaries
UKKA pregnancy and renal disease guideline
Covering the care of women with CKD who are planning a pregnancy, pregnant, or in the postpartum period
Exercise and lifestyle in CKD guideline
New summary covering recommendations for exercise and lifestyle for people with chronic kidney disease
KDIGO management of glomerular diseases part 3 of 3
Covering the management of glomerular diseases in people of all ages
KDIGO management of glomerular diseases part 2 of 3
Covering the management of glomerular diseases in people of all ages
KDIGO general management of glomerular diseases guideline
Covering the management of glomerular diseases in people of all ages
Educational resources
Anticoagulation management for elderly patients with NVAF, CKD and other comorbidities
This promotional webinar was organised and funded by the Bristol Myers Squibb/Pfizer Alliance and is intended for UK healthcare professionals only.
Click HERE to view ELIQUIS (apixaban) prescribing information and adverse events reporting
Adverse events should be reported. Reporting forms and information can be found at: UK – www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store Adverse events should also be reported to Bristol-Myers Squibb via medical.information@bms.com or 0800 731 1736 (UK).
432-GB-2200204 May 2022